Previous 10 | Next 10 |
3 Ways That Market Trends Impact Penny Stocks Investing in penny stocks can be a highly lucrative endeavor, but understanding the stock market and its trends is key for making money with them. The stock market is a complex system that presents both risks and rewards, and it’s important...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Wit Olszewski / Shutterstock Argo Blockchain (NASDAQ: ARBK ) stock is falling hard on Tuesday after the Bitcoin ( BTC-USD ) mining company warned of financial troubles . According to a press release...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock OpGen (NASDAQ: OPGN ) stock is rocketing higher on Tuesday after posting results from its Unyvero urinary tract infections ( UTI ) clinical trial. This clinical trial covered Unyvero UTI Pan...
A Maryland-based healthcare company is turning heads during Tuesday’s premarket after it was announced that the company said it saw “top line data from its successfully completed Unyvero UTI clinical trial.” Shares of %Opgen ($OPGN) are currently bid up at $0.2297/sha...
OpGen, Inc. (OPGN) Q3 2022 Earnings Conference Call November 10, 2022 16:30 ET Company Participants Alyssa Factor - Investor Relations Associate, Edison Group Oliver Schacht - President & Chief Executive Officer Albert Weber - Chief Financial Officer Co...
OpGen press release ( NASDAQ: OPGN ): Q3 GAAP EPS of -$0.30 misses by $0.19 . Revenue of $448.71M (+36086.3% Y/Y) beats by $447.41M . Cash and cash equivalents were approximately $10.3 million as of September 30, 2022, compared with $36.1 million as of December...
Completes first two commercial customer installations for Acuitas AMR Gene Panel OpGen subsidiary, Curetis, signed collaboration agreement with BioVersys AG and R&D collaboration agreement with FIND for the Unyvero A30 RQ platform Elects Yvonne Schlaeppi as new, inde...
OpGen ( NASDAQ: OPGN ) is scheduled to announce Q3 earnings results on Thursday, November 10th, after market close. The consensus EPS Estimate is -$0.11 and the consensus Revenue Estimate is $1.3M (+4.8% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward ...
OpGen ( NASDAQ: OPGN ) reported Thursday its preliminary revenue of $0.4M for the third quarter, down from $1.2M in Q3 2021. The Maryland-based biotech ended the September quarter with cash balance of about $10.3M. The company further raised a $3.38M in direct stock offeri...
ROCKVILLE, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its third quarter 2022 financial results after the close of the U.S. financial marke...
News, Short Squeeze, Breakout and More Instantly...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...